Severe Hyponatraemia Associated with the Use of Arginine-Vasopressin in Two Neonates with Complex Congenital Heart Disease

J Pediatr Intensive Care. 2020 Sep;9(3):213-215. doi: 10.1055/s-0039-1700963. Epub 2020 Jan 13.

Abstract

We report two cases of neonates with complex congenital heart disease and volume, catecholamine, and corticosteroid refractory shock treated with arginine-vasopressin. Arginine-vasopressin was able to reverse critical hypotension, but both patients developed severe hyponatremia, which recovered after discontinuation of arginine-vasopressin. Close control and prompt substitution of serum sodium is required in neonates with advanced heart failure on high-dose vasopressin therapy.

Keywords: arginine–vasopressin; congenital heart disease; hyponatremia; hypotension; refractory shock.

Publication types

  • Case Reports